chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I experienced left sided chest pain 2 days after the vaccination lasting 2 days. Then 4 days after the vaccine, some back/Lung pain causing difficulty and painful breathing lasting for at least 3 days. I went to the Emergency department 6 days after the vaccination. I am reporting this information on the 8th day of vaccination.
8x10cm back of L arm warm to touch.  Observe - no other Tx.
Experienced a burn moments after the shot and some light headedness. knuckles on left index finger became sore at that time as well. PO suggested Tylenol for the pain. Experienced intermittent tingling in the left arm. Right little finger was asleep an hour later. headache 4 hours later. Injection site was kind of sore and knotty the next few days. Woke up next morning with stiff and sore shoulders, caused loss of strength and movement in both shoulders for about 2 weeks. Used Advil an heating pad to reduce to pain and stiffness.
10 minutes after receiving vaccine I had sudden sharp pains in my right ear.  I have had extensive surgery in and around that ear due to cholesteatoma and perilymph fistula, and I have had some nerve damage to the balance nerve.  The bones of hearing have been removed and replaced with titanium artificial bones that do not work, so I am deaf in that ear.  These pains were severe, as if a number of steak knives were stabbing me at once, but the pain only lasted about a minute and subsided.  3 or 4 minutes later the pain recurred exactly as before but lasted a shorter duration and at a lower level of pain.  The ear felt congested the rest of the day and I avoided driving after getting home.  I have had no further problems, except that I went for more dental work on 2/8, and had a dizzy spell after getting anesthetic, maybe a little heart racing for just 5 minutes or so.
Patient returned on 9/9/12 (had shot on 9/7/12). Arm is black & blue as well as swollen & red in an area approximately 4 inches long.
The complaint is characterized as a skin rash. The onset of the symptoms have been rapid and they have been occurring for 3 days. The course has been decreasing (pain had improved by visit on 5/10). The skin complaint is described as moderate to severe. The location is described as on the right side of trunk. There has been associated itching. She has a history of chronic back pain: aches. She said this is occurring as well as the new and worse sharp pain. It was worst last night. She was achy Wednesday morning into Thursday after vaccine.  She felt a little better Friday morning, Friday evening she became tired and her back was hurting again. The rash and itching started on Saturday morning, Sunday was worse. There was burning, sharp pains on her side with the rash. Diagnosis of Shingles (B02.9). Started Acyclovir 5%. Apply 3 times daily for 7 days. Follow up in office if symptoms don't subside or get worse.
Case number PHEH2015US021582, is an initial spontaneous report from a nurse received on 21 Oct 2015. This report refers to a 38-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient received FLUVIRIN (batch number: 1517401) intramuscularly at a dose of 1 ml in error on 21 Oct 2015. The case was assessed as non-serious. No adverse event was reported following the maladministration.
Employee is an RN, and feels Inactivate Flu vaccine was given accidentally into her left shoulder joint - not in the deltoid like it is supposed to be given.
Pfizer / BioNTech / Treatment of COVID-19 23May2022; Pfizer / BioNTech / Treatment of COVID-19 23May2022; This is a spontaneous report received from a non-contactable reporter(s) (Physician).  A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 18Dec2020 as dose 1, single (Lot number: EK5730), in left arm, on 08Jan2021 as dose 2, single (Lot number: EK9231), in left arm and on 31Aug2021 as dose 3 (booster), single (Lot number: EW0186) at the age of 38 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Obesity" (unspecified if ongoing); "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Topamax, reaction(s): "Known allergies: Topamax", notes: known allergies Topamax. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Pfizer / BioNTech / Treatment of COVID-19 23May2022". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (23May2022) Positive; (26May2022) Negative, notes: asymptomatic and testing negative. Tested negative for 7 days; (02Jun2022) Negative, notes: antigen test was initially negative this morning but after hours faint line; (02Jun2022) Positive, notes: evening immediately positive on antigen testing. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical information: No other medication in 2weeks. Antiviral details: Product: Covid 19 treatment, Brand: Pfizert, treatment start date: 23May2022, treatment stop date: 27May2022, indication: treatment of covid-19, administrator route: oral. Adverse event: tested positive for Covid early Monday 23May. 2 risk factors and immediately started paxlovid by Thursday 26May was asymptomatic and testing negative. Strictly isolated for 5 days at the time. Tested negative for 7 days, 02Jun mildly symptomatic again (tested metal like the medicine in morning, post-nasal drip) antigen test was initially negative this morning but after hours faint line, 02Jun evening immediately positive on antigen testing.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the current available limited information in the case provided, the causal association between the events and the use of suspect product BNT162B2 cannot be fully excluded.
RN reported pt has hx Vagal response after vaccines in past.  States pt had dizziness, chills, lightheaded.  Pt sent to station with doh nurse lead & ems to lie down on stretcher.  DOH lead stated pt left site no transport
LACK OF FIBROMYALGIA PAIN OR SHOT SEEMS TO HAVE AWAKEN IMMUNE SYSTEM (UNEXPECTED THERAPEUTIC BENEFIT); This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included fibromyalgia, and a bile duct liver disease. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported. Per procedure, no follow-up will be requested for this case. On an unspecified date, the subject experienced lack of fibromyalgia pain or shot seems to have awaken immune system (unexpected therapeutic benefit). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of lack of fibromyalgia pain or shot seems to have awaken immune system (unexpected therapeutic benefit) was not reported. This report was non-serious.
Had COVID about 9 months ago. After having this vaccination, he had fever, chills and rapid heart beat
I had a COVID-19 vaccine (Pfizer, first dose) on December 29th. Felt pain in the left arm next day, very strong pain in my neck, and a Strong headacke that would not stop and worsened since I started antibiotic treatment. I am currently on antibiotic treatment Azithromycin tablets, 250 mg. I also had scabies/other parasite infection that was ongoing for a year since last January. It never stopped. Ivermectin and permethrin did not work;they did not eliminate the infestation. My skin is very irritated and itchy. I continue to have scars, eruptions, with blood or fluid. Very dry skin that is sererily flaking. I may have a nurve damage due to drugs I was prescribed by different Doctors. I also have a pericardial effusion: never was treated for it. I did not see a cardiologist as I was not reffered by thr PCP and NP. I had two recent electrocardiograms;according to doctors they were normal. I saw a NP recently on 01/06/2022. I am still in pain and have a fever. I need your help!
Per mom baby slept for 30 min very heavily and did not wake up for total of 3 hours. Mother read DTAP VIS sheet given on vaccine Administration date.
Low blood sugar. Treated with juice and food. This has happened 3 times in the 3 days that followed the vaccine.
pt states he had the exact same symptoms when he had the covid virus in January 2021.  His symptoms brought him to the ER  on 4/6/21.  Pt was admitted and stayed for 8 days.  He found a weakness in his body and found he was aspirating into his lungs.  He was given a feeding tube and antibiotics.  It took about 7 days for him to recover.  Pt was discharged to home w/ home health and to FU w/ PCP Dr on 4/20/21.  He was taking off diabetic and bp medication.  He went back to the hospital on 5/13/21 for stent placement.  Chest X- Rays shows there was no Pneumonia so he believes the aspiration issue has been resolved.  He sees PCP on 5/20/2021.
My throat feels like it is closing up, headaches, my face is achy, runny nose, congestion
Insomnia and hyperactive mind 2AM to 6AM - 3/8/21 Body aches, exhaustion, headache, mild nausea, fever (104F) 3/8/21 Body aches, exhaustion, fever (101F)- 3/9/21
Red arm, swollen, itchy for 1 1/2 hrs then went away.
No adverse event noted. The vial that this dose was withdrawn from was diluted with Sodium Chloride 23% instead of 0.9%. Contacted Pfizer and they stated that no info was available regarding this scenario and referred me to recommendation of revaccinating this individual.
This spontaneous report as received from a Registered Nurse and refers to a patient of unknown age and gender. Medical history and concomitant medications were not provided. On 02-FEB-2015, the patient was due for a booster for VARIVAX but was given ZOSTAVAX (lot # K009198) instead. No adverse effects were reported. Additional information has been requested.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. On 14-JAN-2015 the patient was vaccinated with ZOSTAVAX (dose, route of administration were not provided, lot # J011548 with expiration date: 19-DEC-2015). No adverse symptoms reported. The ZOSTAVAX did not have previous temperature excursions. ZOSTAVAX was supported with post expiry data. Additional information has been requested.
On February 5, 2022, I had been tired and had a cough and was on vacation. I figured I should test, and it was positive for COVID-19. By telephone I reached out to the COVID-19 hotline, and I got a telehealth visit, and I went to get an official test. I was given the monoclonal antibodies infection infusion on February 9. It's my opinion that it did shorten the symptoms and kept me from dying. On August 15 I was diagnosed with Leukemia.
I still have a very mild sort of ache or very mild cramp sort of feeling in my left shoulder; I still have a very mild sort of ache or very mild cramp sort of feeling in my left shoulder; This is a spontaneous report from a contactable consumer (Patient) reported herself. A 28-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Deltoid Left on 28May2021 09:45 (Batch/Lot Number: EW0183) as 2nd DOSE, SINGLE for covid-19 immunization. The patient medical history and concomitant medication was not reported. The patient did not receive any other vaccine within prior 4 weeks of vaccination. After the administration of 2nd dose of vaccine on 28May2021 like 11 days ago and she still have a very mild sort of ache or very mild cramp sort of feeling in her left shoulder it was a lot more severe and worsened, improved and persisting.it was faded away about 3 days and when she didn't notice it for several days and she started noticing it again about 2 to 3 days ago which would have been 04Jun or 05Jun. No treatment was received. The event outcome is not recovered.  Follow up attempts are needed. Further information has been requested.
I had an unproductive cough, upper respiratory congestion that felt like it was developing into bronchitis which I have had numerous time in the past. My initial rapid test was negative. I called my doctor and he prescribed Keflex and a cough syrup. My symptoms improved by the 29th I was feeling better. I retested myself on Thursday September 29, 2022 and the test was positive. I continued to mask indoors and stay put. I retested on October 1, 2022 and it was still positive. I would say that I am about 90 to 95% recovered. I am no longer coughing.
supratherapeutic INRs/ INR increased; This is a spontaneous report from a contactable health care professional (nurse), via Pfizer sales representative. A patient of unspecified age and gender received BNT162b2 (PFIZER-BIONTECH COVID-19  VACCINE, Solution for injection; lot number and  expiration date: not reported,) via an unspecified route of administration, on an unspecified date, as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not specified, RN did not elaborate on what concomitant medications patients were on. On an unspecified date, the patient experienced supratherapeutic INRs. The nurse mentioned that they have seen many more supratherapeutic INRs due to the Covid vaccine. Within 5-7 days of vaccination, INR appears to increase in patients on warfarin. The nurse stated that this is a very common occurrence. The patient underwent lab tests and procedures which included international normalized ratio: increased on an unspecified date. The outcome of the event is unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report as received from a Licensed Practitioner Nurse referred to a 4 month old male patient who on 17-APR-2013 was accidentally vaccinated with a dose of PNEUMOVAX 23 (dose not reported). No adverse effects were reported. Additional information is not expected.
sore throat; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-May-2021 and was forwarded to Moderna on 28-May-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (sore throat). At the time of the report, OROPHARYNGEAL PAIN (sore throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient was given the flu vaccine by my colleague, on 10/22/17. She noticed a lot of pressure but not painful when receiving the vaccine. She started to experience pain around bedtime and was having difficulty moving her arm. This intense pain lasted for approximately 3 days and then her arm began to get better. Since then, she has had several episodes where she experiences pain and there are times where she needs assistance in getting dressed because she could not move her arm but they are intermittent. Her symptoms seem to be improving and the last time she had the paralysis/numbness was last week (around Dec 1st). The patient stated that the pain seems manageable with ibuprofen but does not want to continue taking it long term.
12/31/2020: Fatigue - lasting 1 day 12/31 - 1/4/2021: Injection site pain 12/5/2021 - Present: Pain underside of left arm raidiating into arm pit  down along left side into left breast initial pain scale is 4/3  increasing to present pain scale of 8 out of 10. Neg redness, neg. swelling.  Palpable extreme pain. Inability to move / use left arm. Pain with motion - reaction is progressing interesting
pain awful/sores minimal; sore's; got shot within a day of shingles diagnosis; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain, skin ulcer and product use in unapproved indication. On an unknown date, the outcome of the pain was not recovered/not resolved and the outcome of the skin ulcer was recovering/resolving and the outcome of the product use in unapproved indication was unknown.   It was unknown if the reporter considered the pain and skin ulcer to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 25-JUN-2022 Reporter's Comments: This case was reported by the patient via interactive digital media. The patient received a dose of Shingles vaccine within a day of his/her shingles diagnosis as well as the patient experienced awful pain, but sores were minimal, and never itched. The patient was on week five and had one sore yet to heal over. Additional Supportive Information: The patient received Shingles vaccines within a day of shingles diagnosis, which led to product use in unapproved indication. The follow-up would not possible as no contact details were available.
Body akes all night. Left-arm hurt. Had sweats and was unable to sleep all night.
Redness, pain and warm to touch at site started evening of injection - next day swelling progressed from site - am resolved in 2 days with cool compress pain medication
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 25Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 67 years, in left arm for covid-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history included: "GERD" (unspecified if ongoing); "hypertension" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "chronic rhinitis" (unspecified if ongoing); "known allergies: passion fruit and mangoes" (unspecified if ongoing), notes: known allergies: passion fruit and mangoes. The patient's concomitant medications were not reported. Past drug history included: Lisinopril, reaction(s): "known allergies: Allergies to Lisinopril", notes: known allergies: Allergies to Lisinopril; Lactose, reaction(s): "known allergies: Allergies to lactose", notes: known allergies: Allergies to lactose. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of covid-19, drug ineffective.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Severe pain in upper right arm where shot was administrated. Pain is continuous and lessens during movement.
(R) Posterior arm - 1 area maculopapular 5 cm diam. erythema (MENACTRA) (B) Posterior arm - 1 area maculopapular 15 cm diam. (VARICELLA)
Initial unsolicited misuse report received from a nurse on 13 Dec 2016. This case involves patient who was vaccinated with valid dose of FLUZONE ID on an unknown date. It was reported that when nurse attempted to deploy the safety shield her grazed her thumb. It was a case of needle injury and occupational exposure. No adverse event was reported. List of documents held by sender: none.
This case was reported by a healthcare professional and described the occurrence of amenorrhea in a 14-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). Concurrent medical conditions included BACTRIM allergy, epigastric pain and sore throat. On 13 April 2011 at 14:30 the subject received 1st dose of CERVARIX (.5 ml, unknown route, right arm). In April 2011, less than one month after vaccination with CERVARIX, the subject experience amenorrhea and on 01 February 2012 experienced an ovarian cyst. The subject was administered the CERVARIX on 13 April 2011. In July 2011, the subject was seen by the healthcare professional and did not mention the amenorrhea. In November 2011, the subject was seen by the healthcare professional and the subject's mother reported that the subject had not had her period since April 2011. The subject was referred to Obstetrics and Gynecology who found a right ovarian cyst on 01 February 2012 by ultrasound. At the time of reporting the outcome of the events was unspecified. The vaccination course with CERVARIX was discontinued. On 06 March 2012, updated lot number information was received from a safety review. The lot number was reported as AHPV096AD from the reporter; however, based on safety lot number review, the lot was updated to APVA096AD. Follow up information received from the healthcare professional on 14 March 2012. The healthcare professional reported that the subject experienced the events on 13 April 2011 and the events resolved on 05 February 2012. The healthcare professional noted that the events were not serious. According to the healthcare professional, the CERVARIX immunization series has been delayed until the subject's parent decides to continue.
Patient was given an adult dose of Pfizer monovalent COVID-19 vaccine instead of the authorized Pfizer 5-11 year dose.
Myalgia REDNESS, SWELLING AROUND INJECTION SITE LASTING 48 HOURS, HARD KNOT, INCREASED REDNESS DURING THAT 48 HRS; REDNESS GONE ABOUT 72 HOURS LATER THEN ITCHING STARTED LASTING TO PRESENT DAY; AREA NOW WITH 6X6 INDURATED, CALORIC, ERYTHEMIC AREA TO RIGHT DELTOID Narrative:
She received a fluzone high dose influenza vaccine on 10/11/2010.  Later that day she experienced extremely red eyes (about 4:00 PM) by 8:00 PM that day she was experiencing chills, fever, temp (101-102) with nausea and headache.  This lasted from 8:00 pm- 3:00 am.  The next day she was feeling much better with only a slight headache behind her eyes and on the top of her head with pink sclera.  She states had a headache for about 3 days.
Pt presented to clinic for 1st dose of Pfizer Covid-19 vaccination. Pt and Mother stated pt's birth date was 9/2/2009 and received a 1st dose of Pfizer covid-19 vaccine. Upon entering data into state registry, we discovered pt's birthdate is 9/20/2009. Mother confirmed birthdate was 9/20/2009 and stated she had lied on the paperwork. She was informed that her child will not receive a second dose until child was 12 years old.
Approx. 2 weeks, post vax, pt had shaking of the left leg and right arm for about 20-30 seconds. Pt appeared to respond to mother during the episode of shaking. The arms and legs were not shaking simultaneously. Pt continued to eat well.
08/18/2021 Routine  Covid19 Testing = Positive/Asymptomatic
About 4 to 5 minutes after inoculation, I suddenly fainted and was wheezing(my husband said).  When I began to come to, a minute or two later, it was a extremely violent rushing back.  I was gasping for breath.  I had cold sweat and felt like I was weak and in shock and nauseous.  After a time of gaining strength I went home and was fine except for feeling like I had the flu and fatigue for about 24 hours.